Literature DB >> 21793759

Counterfeit bevacizumab and endophthalmitis.

Xiaodong Sun, Xun Xu, Xi Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21793759     DOI： 10.1056/NEJMc1106415

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Assessment of three successive treatments of ranibizumab on neovascular macular degeneration by OCT angiography.

Authors:  Juming Zhu; Qing Peng; Tu Su; Minli Wang; Fang Wang
Journal:  Exp Ther Med       Date:  2020-11-19       Impact factor: 2.447

2.  An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.

Authors:  Roger A Goldberg; Harry W Flynn; Ryan F Isom; Darlene Miller; Serafin Gonzalez
Journal:  Am J Ophthalmol       Date:  2012-02       Impact factor: 5.258

Review 3.  After counterfeit Avastin®--what have we learned and what can be done?

Authors:  Tim K Mackey; Raphael Cuomo; Camille Guerra; Bryan A Liang
Journal:  Nat Rev Clin Oncol       Date:  2015-03-03       Impact factor: 66.675

4.  Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.

Authors:  Roger A Goldberg; Harry W Flynn; Darlene Miller; Serafin Gonzalez; Ryan F Isom
Journal:  Ophthalmology       Date:  2013-02-28       Impact factor: 12.079

5.  Growth of Scytalidium sp. in a counterfeit bevacizumab bottle.

Authors:  Gerardo Garcia-Aguirre; Virginia Vanzinni-Zago; Hugo Quiroz-Mercado
Journal:  Indian J Ophthalmol       Date:  2013-09       Impact factor: 1.848

6.  A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.

Authors:  Morteza Entezari; Saeed Karimi; Hamid Ahmadieh; Amir Hossein Mahmoudi; Hamid Parhizgar; Mehdi Yaseri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

Review 7.  Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines.

Authors:  Peter K Kaiser; Alan F Cruess; Peter Bogaert; Kamlesh Khunti; Simon P Kelly
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-12       Impact factor: 3.117

8.  Responding to the pandemic of falsified medicines.

Authors:  Gaurvika M L Nayyar; Amir Attaran; John P Clark; M Julia Culzoni; Facundo M Fernandez; James E Herrington; Megan Kendall; Paul N Newton; Joel G Breman
Journal:  Am J Trop Med Hyg       Date:  2015-04-20       Impact factor: 2.345

9.  Intravitreal administration of bevacizumab: pros and cons.

Authors:  Simin Dashti-Khavidaki; Mohammad Abdollahi
Journal:  Daru       Date:  2015-04-21       Impact factor: 3.117

10.  An outbreak of Ralstonia pickettii endophthalmitis following intravitreal methotrexate injection.

Authors:  Himadri Choudhury; Animesh Jindal; Avinash Pathengay; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.